Biotech-Focused Fund Adds Million: Immunome Bet Surges
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Points can sometimes offer greater rewards than cash back. Learn when to choose points to maximize your financial advantages.
27,793 articlesA leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
A once-celebrated treasure hunter exits federal custody after a decade behind bars, as investors weigh the legal fall...
A letter allegedly from Sam Bankman-Fried is under intense scrutiny as prosecutors question its authenticity. Amid fa...
A civil social-media debate this spring highlighted a looming fight over who will own payments: Visa or on-chain stab...
A new Microsoft AI diffusion map shows ordinary Americans across states are adopting AI at surprising rates, not just...
Three months after the Hormuz disruption, oil prices remain subdued. Record U.S. exports, a slowdown in Chinese deman...
Arianna Huffington doesn’t believe true work-life balance exists, opting for a strict end-of-day boundary by charging...
When North West stepped onto the Paris stage with electric blue hair and punk flair, she sparked more than headlines—...
A finish-line photo set reveals more than endurance — it shows how family support powers fundraising. Learn how to tu...
The S&P 500 is doing something seen years, signaling a shift in market risk. This guide outlines a single, actionable...
Public XRPL metrics show a sharp drop in activity after the XLS-81 rollout. Analysts say the move may reflect a shift...
Analysts warn that Nvidia's GTC event may not deliver the dramatic stock move some investors were banking on. The con...